Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,308
archived clinical trials in
Hepatitis

A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
Infect. Disease Specialists
mi
from
Decatur, GA
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
Infect. Disease Specialists
mi
from
Decatur, GA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
Indiana University Health - University Hospital
mi
from
Indianapolis, IN
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
Indiana University Health - University Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
Digestive Disease Associates, PA
mi
from
Baltimore, MD
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
Digestive Disease Associates, PA
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
Johns Hopkins University
mi
from
Lutherville, MD
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
Johns Hopkins University
mi
from
Lutherville, MD
Click here to add this to my saved trials
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
Washington University School of Medicine
mi
from
Saint Louis, MO
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
Southwest CARE Center
mi
from
Sante Fe, NM
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
Southwest CARE Center
mi
from
Sante Fe, NM
Click here to add this to my saved trials
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
Binghamton Gastroenterology Associates, PC
mi
from
Binghamton, NY
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
Binghamton Gastroenterology Associates, PC
mi
from
Binghamton, NY
Click here to add this to my saved trials
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
University of Cincinnati
mi
from
Cincinnati, OH
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
Healthcare Research Consultants
mi
from
Tulsa, OK
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
Healthcare Research Consultants
mi
from
Tulsa, OK
Click here to add this to my saved trials
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
Oregon Health and Science University
mi
from
Portland, OR
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
Lehigh Valley Health Network
mi
from
Allentown, PA
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
Lehigh Valley Health Network
mi
from
Allentown, PA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
University Gastroenterology
mi
from
Providence, RI
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
University Gastroenterology
mi
from
Providence, RI
Click here to add this to my saved trials
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
Miriam Hospital
mi
from
Providence, RI
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
Tarrant County Inf Dis Assoc
mi
from
Fort Worth, TX
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
Tarrant County Inf Dis Assoc
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
Cure C Consortium
mi
from
Houston, TX
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
Cure C Consortium
mi
from
Houston, TX
Click here to add this to my saved trials
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
Clinical Research Centers Of America
mi
from
Murray, UT
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
Clinical Research Centers Of America
mi
from
Murray, UT
Click here to add this to my saved trials
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
Mcguire D V A M C
mi
from
Richmond, VA
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
Mcguire D V A M C
mi
from
Richmond, VA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
Harborview Medical Center
mi
from
Seattle, WA
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
Precision Research Institute, LLC
mi
from
San Diego, CA
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
Precision Research Institute, LLC
mi
from
San Diego, CA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
University of California at San Francisco
mi
from
San Francisco, CA
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
University of Colorado
mi
from
Aurora, CO
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
University of Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
Henry Ford Health System
mi
from
Detroit, MI
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
Henry Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated:  9/24/2015
University of Texas Health Science Center at Houston
mi
from
Houston, TX
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)
Status: Enrolling
Updated: 9/24/2015
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Study of IDN-6556 in Patients With Severe AH and Contradictions to Steroid Therapy
A Placebo-Controlled, Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Patients With Severe Alcoholic Hepatitis and Contraindications to Corticosteroid Therapy
Status: Enrolling
Updated:  9/25/2015
Indiana University
mi
from
Indianapolis, IN
Study of IDN-6556 in Patients With Severe AH and Contradictions to Steroid Therapy
A Placebo-Controlled, Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Patients With Severe Alcoholic Hepatitis and Contraindications to Corticosteroid Therapy
Status: Enrolling
Updated: 9/25/2015
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study of IDN-6556 in Patients With Severe AH and Contradictions to Steroid Therapy
A Placebo-Controlled, Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Patients With Severe Alcoholic Hepatitis and Contraindications to Corticosteroid Therapy
Status: Enrolling
Updated:  9/25/2015
Virginia Commonwealth University
mi
from
Richmond, VA
Study of IDN-6556 in Patients With Severe AH and Contradictions to Steroid Therapy
A Placebo-Controlled, Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Patients With Severe Alcoholic Hepatitis and Contraindications to Corticosteroid Therapy
Status: Enrolling
Updated: 9/25/2015
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Study of IDN-6556 in Patients With Severe AH and Contradictions to Steroid Therapy
A Placebo-Controlled, Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Patients With Severe Alcoholic Hepatitis and Contraindications to Corticosteroid Therapy
Status: Enrolling
Updated:  9/25/2015
The Mayo Clinic
mi
from
Rochester, MN
Study of IDN-6556 in Patients With Severe AH and Contradictions to Steroid Therapy
A Placebo-Controlled, Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Patients With Severe Alcoholic Hepatitis and Contraindications to Corticosteroid Therapy
Status: Enrolling
Updated: 9/25/2015
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals
An Open Label Non-Randomized Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals
An Open Label Non-Randomized Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Long-Term Therapy With Ribavirin for Chronic Hepatitis C
Long-Term Therapy With Ribavirin for Chronic Hepatitis C
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Long-Term Therapy With Ribavirin for Chronic Hepatitis C
Long-Term Therapy With Ribavirin for Chronic Hepatitis C
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Genetics of Hepatitis C Virus Infection
Immunogenetics of Hepatitis C Virus Infection
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Genetics of Hepatitis C Virus Infection
Immunogenetics of Hepatitis C Virus Infection
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Long-Term Lamivudine Therapy for Chronic Hepatitis B
Long-Term Lamivudine Therapy for Chronic Hepatitis B
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Long-Term Lamivudine Therapy for Chronic Hepatitis B
Long-Term Lamivudine Therapy for Chronic Hepatitis B
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Association Between Hepatitis C Virus Infection and Hematologic and Thyroid Cancers
Associations of Hematologic Malignancies and Thyroid Cancer With HCV Infection Among US Military Veterans
Status: Enrolling
Updated:  9/26/2015
Houston Veterans AFfairs Medical Center
mi
from
Houston, TX
Association Between Hepatitis C Virus Infection and Hematologic and Thyroid Cancers
Associations of Hematologic Malignancies and Thyroid Cancer With HCV Infection Among US Military Veterans
Status: Enrolling
Updated: 9/26/2015
Houston Veterans AFfairs Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Transplant-Related Accelerated Progression of Hepatitis C
Transplant-Related Accelerated Progression of Hepatitis C (TRAP-C)
Status: Enrolling
Updated:  9/26/2015
Georgetown University
mi
from
Washington,
Transplant-Related Accelerated Progression of Hepatitis C
Transplant-Related Accelerated Progression of Hepatitis C (TRAP-C)
Status: Enrolling
Updated: 9/26/2015
Georgetown University
mi
from
Washington,
Click here to add this to my saved trials
Transplant-Related Accelerated Progression of Hepatitis C
Transplant-Related Accelerated Progression of Hepatitis C (TRAP-C)
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Transplant-Related Accelerated Progression of Hepatitis C
Transplant-Related Accelerated Progression of Hepatitis C (TRAP-C)
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Transplant-Related Accelerated Progression of Hepatitis C
Transplant-Related Accelerated Progression of Hepatitis C (TRAP-C)
Status: Enrolling
Updated:  9/26/2015
Inova Fairfax Hospital
mi
from
Falls Church, VA
Transplant-Related Accelerated Progression of Hepatitis C
Transplant-Related Accelerated Progression of Hepatitis C (TRAP-C)
Status: Enrolling
Updated: 9/26/2015
Inova Fairfax Hospital
mi
from
Falls Church, VA
Click here to add this to my saved trials
MRI to Measure Liver Fat Content
Validation of (1)H-Magnetic Resonance Spectroscopy for Quantification of Hepatic Triglyceride Content
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
MRI to Measure Liver Fat Content
Validation of (1)H-Magnetic Resonance Spectroscopy for Quantification of Hepatic Triglyceride Content
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated:  9/29/2015
Scripps Clinic
mi
from
La Jolla, CA
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated: 9/29/2015
Scripps Clinic
mi
from
La Jolla, CA
Click here to add this to my saved trials
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated:  9/29/2015
Peter J. Ruane, MD, Inc.
mi
from
Los Angeles, CA
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated: 9/29/2015
Peter J. Ruane, MD, Inc.
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated:  9/29/2015
National Research Institute
mi
from
Los Angeles, CA
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated: 9/29/2015
National Research Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated:  9/29/2015
Anthony M. Mills Md Inc
mi
from
Los Angeles, CA
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated: 9/29/2015
Anthony M. Mills Md Inc
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated:  9/29/2015
Huntington Medical Research Institutes
mi
from
Pasadena, CA
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated: 9/29/2015
Huntington Medical Research Institutes
mi
from
Pasadena, CA
Click here to add this to my saved trials
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated:  9/29/2015
Precision Research Institute, LLC
mi
from
San Diego, CA
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated: 9/29/2015
Precision Research Institute, LLC
mi
from
San Diego, CA
Click here to add this to my saved trials
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated:  9/29/2015
Medical Associates Research Group
mi
from
San Diego, CA
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated: 9/29/2015
Medical Associates Research Group
mi
from
San Diego, CA
Click here to add this to my saved trials
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated:  9/29/2015
Quest Clinical Research
mi
from
San Francisco, CA
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated: 9/29/2015
Quest Clinical Research
mi
from
San Francisco, CA
Click here to add this to my saved trials
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated:  9/29/2015
Midland Florida Clinical Research Center, LLC
mi
from
DeLand, FL
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated: 9/29/2015
Midland Florida Clinical Research Center, LLC
mi
from
DeLand, FL
Click here to add this to my saved trials
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated:  9/29/2015
University of Florida Hepatology Research
mi
from
Gainesville, FL
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated: 9/29/2015
University of Florida Hepatology Research
mi
from
Gainesville, FL
Click here to add this to my saved trials
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated:  9/29/2015
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated: 9/29/2015
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
Click here to add this to my saved trials
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated:  9/29/2015
Gastrointestinal Specialists of Georgia
mi
from
Marietta, GA
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated: 9/29/2015
Gastrointestinal Specialists of Georgia
mi
from
Marietta, GA
Click here to add this to my saved trials
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated:  9/29/2015
DuPage Medical Group
mi
from
Downers Grove, IL
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated: 9/29/2015
DuPage Medical Group
mi
from
Downers Grove, IL
Click here to add this to my saved trials
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated:  9/29/2015
Mercy Medical Center
mi
from
Baltimore, MD
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Naive and Treatment Experienced Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated: 9/29/2015
Mercy Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials